Harry Al-Wassiti

Experts / Harry Al-Wassiti

Bioengineer and Research Fellow, Monash University

More from this expert

Infectious diseases

Clinical Articles

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data

Infectious diseases

Clinical Articles

Frontrunners for Australia’s COVID-19 vaccine

On Sunday, the Australian government announced it would put A$6 million towards the research and development of three local COVID-19 vaccine candidates, via the Medical Research Future Fund.

Frontrunners for Australia’s COVID-19 vaccine

On Sunday, the Australian government announced it would put A$6 million towards the research and development of three local COVID-19 vaccine candidates, via the Medical Research Future Fund.

By Harry Al-Wassiti

Clinical Articles

Infectious diseases

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data

By Harry Al-Wassiti

Clinical Articles

Infectious diseases

Harry Al-Wassiti

Bioengineer and Research Fellow, Monash University

More from this expert

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data

Frontrunners for Australia’s COVID-19 vaccine

On Sunday, the Australian government announced it would put A$6 million towards the research and development of three local COVID-19 vaccine candidates, via the Medical Research Future Fund.

Frontrunners for Australia’s COVID-19 vaccine

On Sunday, the Australian government announced it would put A$6 million towards the research and development of three local COVID-19 vaccine candidates, via the Medical Research Future Fund.

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.

Harry Al-Wassiti

Bioengineer and Research Fellow, Monash University

More from this expert

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data

Frontrunners for Australia’s COVID-19 vaccine

On Sunday, the Australian government announced it would put A$6 million towards the research and development of three local COVID-19 vaccine candidates, via the Medical Research Future Fund.

Frontrunners for Australia’s COVID-19 vaccine

On Sunday, the Australian government announced it would put A$6 million towards the research and development of three local COVID-19 vaccine candidates, via the Medical Research Future Fund.

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.